{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Ligand Pharmaceuticals Incorporated"},"Symbol":{"label":"Symbol","value":"LGND"},"Address":{"label":"Address","value":"5980 HORTON STREET,SUITE 405, EMERYVILLE, California, 94608, United States"},"Phone":{"label":"Phone","value":"+1 858 550-7500"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material."},"CompanyUrl":{"label":"Company Url","value":"https://www.ligand.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Paul J. Hadden","title":"SVP-Investments & Business Development"},{"name":"Todd C. Davis","title":"Chief Executive Officer & Director"},{"name":"Vincent Antle","title":"SVP-Technical Operations & Quality Assurance"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}